These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28166667)

  • 1. Caeruloplasmin oxidase activity: measurement in serum by use of o-dianisidine dihydrochloride on a microplate reader.
    Stepien KM; Guy M
    Ann Clin Biochem; 2018 Jan; 55(1):149-157. PubMed ID: 28166667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
    Merle U; Eisenbach C; Weiss KH; Tuma S; Stremmel W
    J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of ferroxidase activity of ceruloplasmin in the diagnosis of Wilson's disease.
    Fleming JJ; Santhosh S; Selvakumar R; Jose A; Eapen CE
    Indian J Clin Biochem; 2009 Jan; 24(1):15-22. PubMed ID: 23105801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
    Gollan JL; Stocks J; Dormandy TL; Sherlock S
    J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
    Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caeruloplasmin isoforms in Wilson's disease in neonates.
    Chowrimootoo GF; Scowcroft H; Seymour CA
    Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F198-201. PubMed ID: 10194991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease.
    Graul RS; Epstein O; Sherlock S; Scheuer PJ
    Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease.
    Evans PJ; Bomford A; Halliwell B
    Free Radic Res Commun; 1989; 7(1):55-62. PubMed ID: 2806955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper distribution among serum proteins in paediatric liver disorders and malignancies.
    Barrow L; Tanner MS
    Eur J Clin Invest; 1988 Dec; 18(6):555-60. PubMed ID: 3147183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a different caeruloplasmin assay method on the relationship between serum copper and caeruloplasmin.
    Twomey PJ
    Postgrad Med J; 2008 Oct; 84(996):549-51. PubMed ID: 19017841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct measurement of serum non-caeruloplasmin copper in liver disease.
    Frommer DJ
    Clin Chim Acta; 1976 May; 68(3):303-7. PubMed ID: 1277546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.
    Siotto M; Pasqualetti P; Marano M; Squitti R
    J Neural Transm (Vienna); 2014 Oct; 121(10):1281-6. PubMed ID: 24663495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody against the active site of caeruloplasmin and the ELISA system detecting active caeruloplasmin.
    Hiyamuta S; Ito K
    Hybridoma; 1994 Apr; 13(2):139-41. PubMed ID: 7519580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pros and cons of immunochemical and enzymatic method in the diagnosis of Wilson's disease.
    Gnanou JV; Thykadavil VG; Thuppil V
    Indian J Med Sci; 2006 Sep; 60(9):371-5. PubMed ID: 16940686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper:caeruloplasmin ratio.
    Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
    J Clin Pathol; 2007 Apr; 60(4):441-2. PubMed ID: 17405985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.